FDA Expands Access To Over-the-Counter Naloxone Nasal Spray For Opioid Overdose

Source Summary

The U.S. FDA has approved Rextovy, a 4 mg naloxone hydrochloride nasal spray, as an additional over-the-counter (OTC) option for reversing opioid overdose, broadening public access to a life-saving medication.